2014
DOI: 10.1097/00003643-201406001-00330
|View full text |Cite
|
Sign up to set email alerts
|

The effect of dexamethasone on cognitive decline after cardiac surgery: a randomized clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
37
0
2

Year Published

2015
2015
2020
2020

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 18 publications
(40 citation statements)
references
References 0 publications
1
37
0
2
Order By: Relevance
“…Table 1 shows the characteristics of the included studies. Four of the included studies involved cardiac surgery [22][23][24][25], while the remaining one involved microvascular decompression surgery [26].…”
Section: Study Selectionmentioning
confidence: 99%
See 2 more Smart Citations
“…Table 1 shows the characteristics of the included studies. Four of the included studies involved cardiac surgery [22][23][24][25], while the remaining one involved microvascular decompression surgery [26].…”
Section: Study Selectionmentioning
confidence: 99%
“…Four studies used a two-arm design in comparing dexamethasone to placebo except 1, which used a three-arm design [26]. Three studies assessed the effects of dexamethasone on POCD [22,24,26], while two studies investigated the effects of dexamethasone on POD [23,25].…”
Section: Study Characteristicsmentioning
confidence: 99%
See 1 more Smart Citation
“…Пациенты пожилого и старческого возраста находятся в группе риска развития послеоперационной когнитивной дисфункции. Оценка когнитивного статуса должна проводиться до операции и в послеоперационный период [105][106][107] Уровень достоверности (доказательности) В Уровень убедительности рекомендации I дексаметазон [119], а также ишемическое прекондиционирование [120] могут потенциально снизить частоту ПОКД. Кроме того, сочетанное применение мониторинга биспектрального индекса и церебральной оксиметрии также, возможно, может быть полезно в профилактике данного осложнения [121].…”
Section: положение 11unclassified
“…Remacemide, another NMDA receptor antagonist, was shown to provide minimal protection against POCD at 8 weeks after cardiac surgery . Recently, a large prospective trial using high‐dose dexamethasone to obtund the inflammatory response in cardiac surgery failed to reduce the incidence of POCD …”
Section: Therapeutic Strategies For Pocdmentioning
confidence: 99%